H-ferritin engineered nanoplatform reprograms metabolism and immunity for glioblastoma immunotherapy
Fields of Study & Subjects
interferon and immune responses
Cancer
Hypoxia
and Metabolism
Nanoplatforms for cancer theranostics
Publication details
- Journal / source
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Volume
- 391
- Pages
- 114613–114613
- Publication date
- 7 January 2026
- Language
- EN